{
    "clinical_study": {
        "@rank": "11570", 
        "arm_group": [
            {
                "arm_group_label": "Diet therapy", 
                "arm_group_type": "Experimental", 
                "description": "The patients in this arm were educated to  follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks."
            }, 
            {
                "arm_group_label": "Control Group", 
                "arm_group_type": "Other", 
                "description": "The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of especial diet therapy\n      \"Anti-inflammatory Diet\" on inflammatory, oxidative stress, and nutritional markers in the\n      context of protein-energy wasting syndrome(PEW) in hemodialysis patients."
        }, 
        "brief_title": "Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Inflammation", 
            "Malnutrition", 
            "Protein Energy Wasting Syndrome", 
            "Oxidative Stress", 
            "Diet Therapy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Wasting Syndrome", 
                "Malnutrition"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who are on hemodialysis(HD) at least two times a week for 3months or more\n             without any internment illness or admission\n\n        Exclusion Criteria:\n\n          -  Hospitalization because of sepsis or surgery 3 months prior to intervention\n\n          -  Cirrhosis\n\n          -  Hepatitis virus infection\n\n          -  Human Immunodeficiency virus infection\n\n          -  Acquired Immunodeficiency Syndrome\n\n          -  Active malignancy\n\n          -  Active infection\n\n          -  Absence of communication\n\n          -  Mental Impairment\n\n          -  Terminal illness\n\n          -  Tube feedings\n\n          -  Total parenteral nutrition\n\n          -  Pregnancy\n\n          -  Not previously seen by a dietitian within 3 months prior to enrollment in the study\n\n          -  Not expected to be transplanted within 6 months after the enrollment in the study\n\n          -  Absence of malnutrition from a cause other than end stage renal disease(ESRD)\n\n          -  Psychiatric conditions, preventing adherence to intervention\n\n          -  Consuming immunosuppressive drugs or taking antioxidant supplements including Vitamin\n             E, Vitamin C, N-acetyl- cysteine (NAC), Pentoxifylline, Lipoic acid,Fish-oil extracts\n             (omega-3 fatty acids), Soy extracts(isoflavones), Green-tea preparations, Pomegranate\n             extracts, Grape extracts within 2 months prior to enrollment in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874106", 
            "org_study_id": "916425"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diet therapy", 
                "description": "The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.", 
                "intervention_name": "Diet Therapy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control Group", 
                "description": "The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.", 
                "intervention_name": "Control Group", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anti-Inflammatory Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hemodialysis", 
            "Diet", 
            "Inflammation", 
            "Malnutrition"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shiraz", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Fars"
                }, 
                "name": "Shiraz University of Medical Sciences, Department of Nutrition"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients", 
        "overall_official": [
            {
                "affiliation": "Shiraz University of Medical Sciences, Faculty of Nutrition", 
                "last_name": "Zohreh Mazloom, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Shiraz University of Medical Sciences, Nephrology Urology Research Center", 
                "last_name": "Mohammadmahdi Sagheb, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Shiraz University of Medical Sciences vice chancellor for research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in serum Albumin", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874106"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shiraz University of Medical Sciences", 
            "investigator_full_name": "Maryam Ekramzadeh, PhD", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Subjective Global Assessment (SGA) score", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in Malnutrition-inflammation score(MIS)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum C-Reactive Protein(CRP)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum malondialdehyde(MDA)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum Interleukin-6(IL-6)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum total antioxidant capacity(TAC)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum ferritin", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum total iron binding capacity(TIBC)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum urea nitrogen", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum creatinine", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in serum phosphorus", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in body fat mass index(BFMI)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in fat free mass index(FFMI)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "Change in body cell mass(BCM)", 
                "safety_issue": "No", 
                "time_frame": "10 weeks"
            }
        ], 
        "source": "Shiraz University of Medical Sciences", 
        "sponsors": {
            "collaborator": {
                "agency": "Shiraz University of Medical Sciences", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Maryam Ekramzadeh, PhD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}